Curis Lifesciences (NSE:CURIS) FCF Margin %: 0.00% (As of Mar. 2026)


NSE:CURIS Curis Lifesciences Ltd NSE:CURIS
19 GF Score
Price ₹101.50
! 2 Warning Signs
View Full Analysis

What is Curis Lifesciences FCF Margin %?

Curis Lifesciences NSE:CURIS -0.49% 19 FCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates NSE:CURIS with a GF Score™ of 19/100. The stock has 2 warning signs investors should review. Among 958 Drug Manufacturers companies, Curis Lifesciences ranks worse than 64.72% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Curis Lifesciences's Free Cash Flow for the six months ended in Mar. 2026 was ₹0.0 Mil. Curis Lifesciences's Revenue for the six months ended in Mar. 2026 was ₹601.6 Mil. Therefore, Curis Lifesciences's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Curis Lifesciences's current FCF Yield % is -2.26%.

The historical rank and industry rank for Curis Lifesciences's FCF Margin % or its related term are showing as below:

NSE:CURIS' s FCF Margin % Range Over the Past 10 Years
Min: -3.88   Med: 0.58   Max: 7.71
Current: -3.08

During the past 4 years, the highest FCF Margin % of Curis Lifesciences was 7.71%. The lowest was -3.88%. And the median was 0.58%.

NSE:CURIS's FCF Margin % is ranked worse than
64.72% of 958 companies
in the Drug Manufacturers industry
Industry Median: 2.445 vs NSE:CURIS: -3.08

Curis Lifesciences FCF Margin % Related Terms

Curis Lifesciences FCF Margin % Historical Data

* Premium members only.

The historical data trend for Curis Lifesciences's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Curis Lifesciences FCF Margin % Chart

Curis Lifesciences Annual Data
Trend Mar23 Mar24 Mar25 Mar26
FCF Margin %
7.71 0.58 -3.88 0.00

Curis Lifesciences Semi-Annual Data
Mar23 Mar24 Mar25 Mar26
FCF Margin % 7.71 0.58 -3.88 0.00

NSE:CURIS vs ZTS, UTHR: FCF Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Curis Lifesciences's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Curis Lifesciences FCF Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Curis Lifesciences's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Curis Lifesciences's FCF Margin % falls into.


NSE:CURIS
19GF Score
Curis Lifesciences Ltd NSE:CURIS
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Curis Lifesciences FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Curis Lifesciences's FCF Margin for the fiscal year that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (A: Mar. 2026 )/Revenue (A: Mar. 2026 )
=0/601.619
=0.00 %

Curis Lifesciences's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=0/601.619
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Curis Lifesciences (NSE:CURIS) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Curis Lifesciences and its competitors. According to the industry distribution chart, Curis Lifesciences ranks #620 out of 958 companies in the Drug Manufacturers industry, placing it in the top 64.7%.
Is Curis Lifesciences' FCF Margin % too high?
Curis Lifesciences' current FCF Margin % is 0.00%. Based on the distribution chart, Curis Lifesciences ranks #620 out of 958 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Curis Lifesciences has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Curis Lifesciences' FCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Curis Lifesciences ranks #620 out of 958 companies for FCF Margin %. This places Curis Lifesciences in the lower half of its industry. The industry median FCF Margin % is 2.45. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.45, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Curis Lifesciences and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Curis Lifesciences's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Curis Lifesciences stock overvalued right now?
Curis Lifesciences (NSE:CURIS) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Curis Lifesciences' overall GF Score™ is 19/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Curis Lifesciences (NSE:CURIS), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Curis Lifesciences Business Description

Address PF-23, GIDC Sanand - II, Industrial Acme Pharma, Opposite Teva Pharma, Sanand, Ahmedabad, GJ, IND, 382110
Curis Lifesciences Ltd is in the business of manufacturing of pharmaceutical products. It specializes in the manufacturing of a wide range of pharmaceutical products such as Tablets, Capsules, External Preparations, Oral liquid, and Sterile Ophthalmic Ointments. The company's business verticals are: Loan License manufacturing, Contract Manufacturing, and Direct Export. The company derives revenue from the sale of its pharmaceutical products.
19GF Score

Get the complete analysis for NSE:CURIS

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹101.50
Price